Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized Phase III Study of Neoadjuvant Anti-PD-1 Immunotherapy Plus TP Chemotherapy Versus TP Chemotherapy or Up-Front Surgery in Resectable Locally Advanced Oral Squamous Cell Carcinoma

NCT05798793 is registered in ClinicalTrials.gov with Hospital of Stomatology, Wuhan University as lead sponsor.

NCT NCT05798793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05798793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized Phase III Study of Neoadjuvant Anti-PD-1 Immunotherapy Plus TP Chemotherapy Versus TP Chemotherapy or Up-Front Surgery in Resectable Locally Advanced Oral Squamous Cell Carcinoma
Lead sponsor
Hospital of Stomatology, Wuhan University
Phase
Phase 3
Overall status
Recruiting
Start date
November 21, 2023
Completion date
October 1, 2026
Enrollment
309 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

oral squamous cell carcinoma